+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Uceris"

Anorectal Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Anorectal Disorders Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Uceris (budesonide) is a corticosteroid medication used to treat mild to moderate ulcerative colitis, a type of inflammatory bowel disease. It is available in both oral and rectal forms, and is typically used in combination with other medications. Uceris works by reducing inflammation in the gastrointestinal tract, which can help reduce symptoms such as abdominal pain, diarrhea, and rectal bleeding. Uceris is part of a larger market of gastrointestinal drugs, which includes medications used to treat a variety of conditions such as irritable bowel syndrome, Crohn's disease, and ulcerative colitis. These medications can be used to reduce inflammation, relieve symptoms, and improve overall quality of life. The Uceris market is highly competitive, with many companies offering similar products. Some of the major players in the market include AbbVie, Allergan, AstraZeneca, Janssen, and Pfizer. Show Less Read more